260
Views
28
CrossRef citations to date
0
Altmetric
Articles

New Biscoumarin Derivatives as Potent α-Glucosidase Inhibitors: Synthesis, Biological Evaluation, Kinetic Analysis, and Docking Study

, , , , , , , , & show all
Pages 915-926 | Received 20 Apr 2018, Accepted 04 Aug 2018, Published online: 02 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Soukaina Chehab, Youssef Merroun, Rachida Ghailane, Said Boukhris & Abdelaziz Souizi. (2023) Na2Ca(HPO4)2, an Efficient, Reusable Eco-Friendly Catalyst for the Synthesis of 1,8-Dioxo-Octahydroxanthenes and Biscoumarin Derivatives. Polycyclic Aromatic Compounds 43:6, pages 4906-4923.
Read now
K. R. Kadam, G. R. Pandhare, A. S. Waghmare, V. D. Murade, N. R. Kamble & V. T. Kamble. (2023) Silica Chemisorbed Bis(Hydrogensulphato)Benzene (SiO2-BHSB) as a New, Environmentally Benign and Recyclable Catalyst for an Efficient Synthesis of Biscoumarin Scaffolds in Water Based Solvent. Polycyclic Aromatic Compounds 43:1, pages 647-664.
Read now
Emad Elahabaadi, Amir Ahmad Salarian & Ehsan Nassireslami. (2022) Design, Synthesis, and Molecular Docking of Novel Hybrids of Coumarin-Dithiocarbamate Alpha-Glucosidase Inhibitors Targeting Type 2 Diabetes Mellitus. Polycyclic Aromatic Compounds 42:7, pages 4317-4327.
Read now
Seyed Esmaeil Sadat-Ebrahimi, Hiva Babania, Maryam Mohammadi-Khanaposhtani, Mohammad Sadegh Asgari, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Azadeh Yahya-Meymandi, Samaneh Zareie, Bagher Larijani, Mahmoud Biglar, Hossein Rastgar, Alireza Foroumadi & Mohammad Mahdavi. (2022) Design, Synthesis, and Biological Evaluation of New Indole-Acrylamide-1,2,3-Triazole Derivatives as Potential α-Glucosidase Inhibitors. Polycyclic Aromatic Compounds 42:6, pages 3157-3165.
Read now
Jay Soni, Nusrat Sahiba, Ayushi Sethiya, Pankaj Teli, Dinesh Kr. Agarwal, Anu Manhas, Prakash Chandra Jha, Deepkumar Joshi & Shikha Agarwal. (2022) Biscoumarin Derivatives as Potent anti-Microbials: Graphene Oxide Catalyzed Eco-Benign Synthesis, Biological Evaluation and Docking Studies. Polycyclic Aromatic Compounds 42:6, pages 2970-2990.
Read now

Articles from other publishers (23)

Mohammed El Behery, Ibrahim M. El-Deen, Manar A. El-Zend & Lamiaa A.A. Barakat. (2023) Design, synthesis and evaluation the bioactivities of novel 8‑methoxy-1-azacoumarin-3-carboxamide derivatives as anti-diabetic agents. Journal of Molecular Structure 1294, pages 136486.
Crossref
Ajay Thakur, Ruchi Bharti, Monika Verma, Renu Sharma, Ajay Sharma, Anshi GuptaVipasha Sharma. (2023) Ultra-Sonicated One-Pot Synthesis of Potent Bioactive Biscoumarin and Polycyclic Pyranodichromenone Scaffolds in Aqueous Media: A Complementary Tool to Organic Synthesis. Synthesis 55:19, pages 3129-3144.
Crossref
Fariba Peytam, Faezeh sadat Hosseini, Malak Hekmati, Bahareh Bayati, Mahdis Sadeghi Moghadam, Zahra Emamgholipour, Loghman Firoozpour, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Seyed Esmaeil Sadat-Ebrahimi, Maliheh Barazandeh Tehrani & Alireza Foroumadi. (2023) Imidazo[1,2-c]quinazolines as a novel and potent scaffold of α-glucosidase inhibitors: design, synthesis, biological evaluations, and in silico studies. Scientific Reports 13:1.
Crossref
Faeze Yousefnejad, Mahyar Mohammadi-Moghadam-Goozali, Mohammad Hosein Sayahi, Mohammad Halimi, Ali Moazzam, Maryam Mohammadi-Khanaposhtani, Somayeh Mojtabavi, Mehdi Asadi, Mohammad Ali Faramarzi, Bagher Larijani, Massoud Amanlou & Mohammad Mahdavi. (2023) Design, synthesis, in vitro, and in silico evaluations of benzo[d]imidazole-amide-1,2,3-triazole-N-arylacetamide hybrids as new antidiabetic agents targeting α-glucosidase. Scientific Reports 13:1.
Crossref
Thi-Hong-Truc Phan, Kowit Hengphasatporn, Yasuteru Shigeta, Wanting Xie, Phornphimon Maitarad, Thanyada Rungrotmongkol & Warinthorn Chavasiri. (2023) Designing Potent α-Glucosidase Inhibitors: A Synthesis and QSAR Modeling Approach for Biscoumarin Derivatives. ACS Omega 8:29, pages 26340-26350.
Crossref
Mahtab Rahmani Gavanrudi, Mohammad Halimi, Hossein Najafzadehvarzi, Majid Alikhani, Ali MoazzamSoghra Farzipour, Samanesadat Hosseini, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Ensieh Nasli‐Esfahani, Maryam Mohammadi‐Khanaposhtani & Mohammad Mahdavi. (2023) Discovery of Phthalimide‐1,2,3‐triazole‐ N ‐phenylacetamide Hybrids as Potent α‐Glucosidase Inhibitors: Design, Synthesis, ADMET Prediction, and in vitro and in silico Enzymatic Evaluations . ChemistrySelect 8:26.
Crossref
Sajedeh Safapoor, Mohammad Halimi, Minoo Khalili Ghomi, Milad Noori, Navid Dastyafteh, Shahrzad Javanshir, Samanesadat Hosseini, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Ensieh Nasli-Esfahani, Bagher Larijani, Azadeh Fakhrioliaei, Mohammad G. Dekamin, Maryam Mohammadi-Khanaposhtani & Mohammad Mahdavi. (2023) Synthesis, ADMT prediction, and in vitro and in silico α-glucosidase inhibition evaluations of new quinoline–quinazolinone–thioacetamides . RSC Advances 13:28, pages 19243-19256.
Crossref
Mehdi Emadi, Mohammad Halimi, Ali Moazzam, Samanesadat Hosseini, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Reza Ghadimi, Ali Akbar Moghadamnia, Ensieh Nasli-Esfahani, Maryam Mohammadi-Khanaposhtani & Mohammad Mahdavi. (2023) Design, synthesis, in vitro anti-α-glucosidase evaluations, and computational studies of new phthalimide-phenoxy-1,2,3-triazole-N-phenyl (or benzyl) acetamides as potential anti-diabetic agents. Scientific Reports 13:1.
Crossref
Alia Mushtaq, Uzma Azam, Saba Mehreen & Muhammad Moazzam Naseer. (2023) Synthetic α-glucosidase inhibitors as promising anti-diabetic agents: Recent developments and future challenges. European Journal of Medicinal Chemistry 249, pages 115119.
Crossref
Maryam Mohammadi‐Khanaposhtani, Milad Noori, Yousef Valizadeh, Navid Dastyafteh, Minoo Khalili Ghomi, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Samanesadat Hosseini, Mahmood Biglar, Bagher Larijani, Hossein Rastegar, Haleh Hamedifar, Roghieh Mirzazadeh & Mohammad Mahdavi. (2022) Synthesis, α‐glucosidase Inhibition, in silico Pharmacokinetic, and Docking Studies Of Thieno[2,3‐b]Quinoline‐Acetamide Derivatives as New Anti‐Diabetic Agents . ChemistrySelect 7:44.
Crossref
Milad Noori, Mryam Rastak, Mohammad Halimi, Minoo Khalili Ghomi, Mrjan Mollazadeh, Maryam Mohammadi-Khanaposhtani, Mohammad Hosein Sayahi, Zahra Rezaei, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Bagher Larijani, Mahmood Biglar, Massoud Amanlou & Mohammad Mahdavi. (2022) Design, synthesis, in vitro, and in silico enzymatic evaluations of thieno[2,3-b]quinoline-hydrazones as novel inhibitors for α-glucosidase. Bioorganic Chemistry 127, pages 105996.
Crossref
Homa Azizian, Keyvan Pedrood, Ali Moazzam, Yousef Valizadeh, Kimia Khavaninzadeh, Ali Zamani, Maryam Mohammadi-Khanaposhtani, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Samanesadat Hosseini, Yaghoub Sarrafi, Hossein Adibi, Bagher Larijani, Hossein Rastegar & Mohammad Mahdavi. (2022) Docking study, molecular dynamic, synthesis, anti-α-glucosidase assessment, and ADMET prediction of new benzimidazole-Schiff base derivatives. Scientific Reports 12:1.
Crossref
Mohammad Sadegh Asgari, Maryam Mohammadi-Khanaposhtani, Zeinab Sharafi, Mohammad Ali Faramarzi, Hossein Rastegar, Ensieh Nasli Esfahani, Fatemeh Bandarian, Parviz Ranjbar Rashidi, Rahmatollah Rahimi, Mahmood Biglar, Mohammad Mahdavi & Bagher Larijani. (2020) Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies. Molecular Diversity 25:2, pages 877-888.
Crossref
Madieh Sadeghpour, Abolfazl Olyaei & Alireza Adl. (2021) 4-Aminocoumarin derivatives: synthesis and applications. New Journal of Chemistry 45:13, pages 5744-5763.
Crossref
Ali Yavari, Maryam Mohammadi-Khanaposhtani, Shahram Moradi, Saeed Bahadorikhalili, Roghayeh Pourbagher, Nasrin Jafari, Mohammad Ali Faramarzi, Ebrahim Zabihi, Mohammad Mahdavi, Mahmood Biglar, Bagher Larijani, Haleh Hamedifar & Mir Hamed Hajimiri. (2021) α-Glucosidase and α-amylase inhibition, molecular modeling and pharmacokinetic studies of new quinazolinone-1,2,3-triazole-acetamide derivatives. Medicinal Chemistry Research 30:3, pages 702-711.
Crossref
Marjan Mollazadeh, Maryam Mohammadi-Khanaposhtani, Yousef Valizadeh, Afsaneh Zonouzi, Mohammad Ali Faramarzi, Parsa Hariri, Mahmood Biglar, Bagher Larijani, Haleh Hamedifar, Mohammad Mahdavi & Nima Sepehri. (2020) 2,4-Dioxochroman Moiety Linked to 1,2,3-triazole Derivatives as Novel α-glucosidase Inhibitors: Synthesis, In vitro Biological Evaluation, and Docking Study. Current Organic Chemistry 24:17, pages 2019-2027.
Crossref
Maryam Mohammadi‐Khanaposhtani, Hoda Yahyavi, Somaye Imanparast, Fereshte Nazemi Harandi, Mohammad Ali Faramarzi, Alireza Foroumadi, Bagher Larijani, Mahmood Biglar & Mohammad Mahdavi. (2019) Benzoylquinazolinone derivatives as new potential antidiabetic agents: α‐Glucosidase inhibition, kinetic, and docking studies. Journal of the Chinese Chemical Society 67:5, pages 856-863.
Crossref
Tadesse Bekele Tafesse, Mohammed Hussen Bule, Mehdi Khoobi, Mohammad Ali Faramarzi, Mohammad Abdollahi & Mohsen Amini. (2020) Coumarin-based Scaffold as α-glucosidase Inhibitory Activity: Implication for the Development of Potent Antidiabetic Agents. Mini-Reviews in Medicinal Chemistry 20:2, pages 134-151.
Crossref
Fariba Peytam, Mehdi Adib, Reihaneh Shourgeshty, Loghman Firoozpour, Mahmoud Rahmanian-Jazi, Mehdi Jahani, Setareh Moghimi, Kouros Divsalar, Mohammad Ali Faramarzi, Somayeh Mojtabavi, Fatemeh Safari, Mohammad Mahdavi & Alireza Foroumadi. (2020) An efficient and targeted synthetic approach towards new highly substituted 6-amino-pyrazolo[1,5-a]pyrimidines with α-glucosidase inhibitory activity. Scientific Reports 10:1.
Crossref
Pankaj Teli, Ayushi Sethiya & Shikha Agarwal. (2019) An Insight View on Synthetic Protocol, Mechanistic and Biological Aspects of Biscoumarin Derivatives. ChemistrySelect 4:47, pages 13772-13787.
Crossref
Zohreh Bakherad, Maryam Mohammadi-Khanaposhtani, Hojjat Sadeghi-Aliabadi, Sepideh Rezaei, Afshin Fassihi, Mohammad Bakherad, Hossein Rastegar, Mahmood Biglar, Lotfollah Saghaie, Bagher Larijani & Mohammad Mahdavi. (2019) New thiosemicarbazide-1,2,3-triazole hybrids as potent α-glucosidase inhibitors: Design, synthesis, and biological evaluation. Journal of Molecular Structure 1192, pages 192-200.
Crossref
Manoj Dhameja & Preeti Gupta. (2019) Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview. European Journal of Medicinal Chemistry 176, pages 343-377.
Crossref
Ensieh Nasli‐Esfahani, Maryam Mohammadi‐Khanaposhtani, Sepideh Rezaei, Yaghoub Sarrafi, Zeinab Sharafi, Nasser Samadi, Mohammad Ali Faramarzi, Fatemeh Bandarian, Haleh Hamedifar, Bagher Larijani, Mirhamed Hajimiri & Mohammad Mahdavi. (2019) A new series of Schiff base derivatives bearing 1,2,3‐triazole: Design, synthesis, molecular docking, and α‐glucosidase inhibition. Archiv der Pharmazie 352:8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.